The Food and Drug Administration has granted Fast Track designation to PMN310 for the treatment of Alzheimer disease.

Neuroanatomical variability is associated with early substance use initiation, according to a cohort study published in JAMA Network Open.

The structured intervention benefit was consistent for APOE ε4 carriers and noncarriers but seemed greater for adults with lower vs higher baseline cognition.

Screening for emotional and cognitive issues after ischemic stroke does not improve societal participation at 1 year.

Topline data were announced from a phase 3 trial evaluating gefurulimab in adults with anti-acetylcholine receptor antibody-positive generalised myasthenia gravis.

Treatment of TBI with magnesium-ibogaine reduces spatiotemporal complexity of brain activity and slows cortical oscillations in the brain at rest.

HealthDay News — Health care provider stigma toward substance use disorder (SUD) varies by condition and provider, according to a study published online July 23 in Addiction.

Dementia with Lewy bodies (DLB), the second most common type of dementia, requires a multifactorial approach to reduce symptoms.

Only 36.8 percent of adolescents diagnosed with cannabis use disorder (CUD) complete treatment, according to a study published online July 22 in Pediatric Repor ...

HealthDay News — Imaging the inner ear during surgical procedures is feasible and allows detection of endolymphatic hydrops, according to a study published online July 23 in Science Translational ...

Migraine is associated with a significantly increased risk for all-cause dementia, Alzheimer disease (AD), and vascular dementia (VaD), particularly among women and patients who have migraine with ...

Remote-scalable CBT-based chronic pain treatments yield modest improvements in high-impact chronic pain compared with usual care.